The antiviral effects of RSV fusion inhibitor, MDT‐637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin

BACKGROUND: Respiratory syncytial virus (RSV) viral load and disease severity associate, and the timing of viral load and disease run in parallel. An antiviral must be broadly effective against the natural spectrum of RSV genotypes and must attain concentrations capable of inhibiting viral replicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young‐In, Pareek, Rajat, Murphy, Ryan, Harrison, Lisa, Farrell, Eric, Cook, Robert, DeVincenzo, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705693/
https://www.ncbi.nlm.nih.gov/pubmed/28990339
http://dx.doi.org/10.1111/irv.12503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705693/
https://www.ncbi.nlm.nih.gov/pubmed/28990339
http://dx.doi.org/10.1111/irv.12503

Ejemplares similares